Programme - Invited Speaker

Life Sciences & Health
Proteogenomic analysis of PARPi-resistant BRCA1-deficient tumors
DR. BHIN, Jinhyuk
Netherlands Cancer Institue
Jinhyuk Bhin completed his Ph.D program in POSTECH (South Korea) under the supervision of Prof. Dr. Daehee Hwang. During his Ph.D program, he applied systems biology approaches to identify key molecular bases in complex biological systems including embryonic stem cell and gastric cancer. He joined the groups of Lodewyk Wessels and Jos Jonkers in NKI at January 2017 as a postdoctoral fellow. His recent project is to discover the resistance factors in response to anticancer drugs in multiple types of breast cancers.
Precision oncology drug development
University of Glasgow
Andrew Biankin is a surgeon-scientist whose research goals are to improve outcomes for individuals with pancreatic cancer through the development of early detection and novel therapeutic strategies based on molecular phenotyping and the delineation and implementation of biomarkers that facilitate clinical decision-making. He contributes to the International Cancer Genome Consortium through extensively characterising the genomic, transcriptomic and epigenomic aberrations in pancreatic cancer, and is extending this knowledge to a personalized model of cancer care, where molecular characteristics guide treatment decisions.
Deciphering the role of genetic structural variation on the gene regulation and disease
DR. JEONG, Hyobin
EMBL, Heidelberg
Hyobin Jeong studied systems biology for her Ph.D. degree in POSTECH under the co-supervision of Prof. Dr. Daehee Hwang and Prof.Dr. Inhee Mook-Jung. The thesis title was "Development of framework for identification of disease related signaling pathways using omics data integration". Since 2018, she is a postdoctoral fellow in EMBL, Heidelberg under the supervision of Dr. Jan Korbel. Her recent research interest is to decipher cell-type dependent impact of genomic structural variation on gene regulation and disease.
Targeting metabolic vulnerabilities of cancer
Technion - Israel Inst of Technology | Cancer Research UK Beatson Institute | Univ of Glasgow
Prof. Gottlieb is Professor of Molecular Cell Biology at the University of Glasgow, a Research Group Leader at the Beatson Institute for Cancer Research, and the Laura & Isaac Perlmutter Chair of Cancer Research at the Technion-Israel Institute of Technology, Israel. Prof. Gottlieb's studies focus on cancer metabolism, combining analytical and organic chemistry with cancer genetics to explore new potential clinical approaches for cancer treatment.
The Potential Role of Bee Products in Human Health: A Metabolomics Approach
University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences
Dr Watson's areas of research involve high resolution mass spectrometry and chromatography applied to metabolomics, bionanalysis and natural products research. He served as local chair and organizer of the Metabolomics Society conference in Glasgow in 2013. His current metabolomics interests are as follows: parasite biology, drosophila biology, cancer cell biology, clinical screening for disease, steroids in models of pulmonary hypertension, and profiling of mammalian milks.
A study of in vivo rat brain tumour model using a flexible multinuclear MR-PET system
DR. CHOI, Chang-hoon
Forschungszentrum Juelich
Dr. Chang-Hoon Choi obtained his PhD in MRI Physics at the University of Aberdeen, UK in 2010 and worked for MR Solutions, UK until 2014. He is an MRI expert and has been working in Forschungszentrum Jülich, Germany as a staff scientist since 2014. His research interests are MRI, MR-PET hardware, and applications using the systems.
Towards cellulose nanocrystal films with controlled selective reflection
University of Luxembourg
Jan Lagerwall (M.Sc. Physics 1997; Ph.D. Materials Science, 2002) is professor in physics at University of Luxembourg. His research focuses on soft matter physics, chemistry and materials science, connecting liquid crystals with many other fields, from fiber spinning and microfluidics to art, architecture and security. The motivation ranges from the scientific beauty to the diverse application opportunities arising through cross fertilization with other disciplines. As postdoctoral researcher Jan worked with N. Clark (Boulder), G. Heppke (Berlin) and F. Giesselmann (Stuttgart). He previously held group leader positions at Martin Luther University Halle-Wittenberg (Germany) and Seoul National University (Korea).
Direct contact imaging device for Live cell monitoring & IVD
MR. LEE, Jongmuk
SOL Inc.
Jongmuk Lee is a CEO and founder of company, SOL Inc. The R&D focus of company is on developing direct contact imaging system capable of live cell monitoring, Point-of-Care(POC), and In-vitro Diagnostics(IVDs). He joined KAIST KEPSI, Korea in 1996 as a senior researcher, where he worked until he joined Siliconfiles, Korea in 2006 as a principal researcher. Mr. Lee received the Minister award from Ministry of Trade, Industry and Energy, Korea in 2015. He received IEC 1906 award from International Electrotechnical Commision(IEC) in 2017 and in same year, He received the Minister award from Ministry of SMEs and Startups, Korea.
Sliding Tethered Ligands: lock and key interactions with a topological twist
Centre National de la Recherche Scientifique
Microparticles as a new platform of cell based assays
Kyung Hee University
Prof. Park Wook earned a 2011 Ph.D., Electrical Engineering (Biophotonics and nanoengineering), Seoul National University and he received Feb, 2012 President’s post-doctoral fellow at Seoul National University for 5 years. He became an Assistant professor at Kyung Hee University in 2012. His recent highlighted research topic is self-organization of maze-like structures via guided wrinkling (in Science advances (2017), where sophisticated three-dimensional (3D) structures found in nature as self-organized by bottom-up processes. He is particularly interested in a localized interface between micro-surfaces and cells using Microstructures. He uses 3D printers to fabricate 3D hydrogel microstructures, as well as hybridizes from the nanostructures to microstructure to mimic cellular environments.
A Study on Early Detection of Diseases Using Machine Learning
DR. AHN, Insung
Korea Institute of Science and Technology Information
Insung Ahn took her first Ph.D. (Biotechnology) from Korea University in 2002, and earned her second Ph.D. (Public Health) from Seoul National University in 2007. Since she joined to the KISTI in 2002, she has been developing various kinds of bioinformatics tools for predicting future outbreak of disease. Dr. Ahn is also a team leader of governmental project named CEVI(Center for Convergent Research of Emerging Virus Infection).
Detecting emerging infectious diseases and outbreaks by the application of statistical algorithms to surveillance data
Public Health England
Andre Charlett has worked in the Statistics, Modelling, and Economics Department of the National Infection Service for the past 25 years, being the Department Head for the past 17 years. His research interests include the evaluation of interventions to control infectious diseases, development of statistical algorithms to detect the emergence of outbreaks, and the role of the gastric microbiome in neurological diseases.
Estimating and modelling the transmissibility of Middle East Respiratory Syndrome CoronaVirus during the 2015 outbreak in the Republic of Korea
DR. ZHANG, Xu-sheng
PhD 2001 Quantitative Epidemiology (Natural Resource Institue, Univ. of Greenwich, UK) 2001 - 2009: Postdoctoral Research Fellow, Centre of Infectious Diseases and Institute of Evolutionary Biology, University of Edinburgh, UK 2009 - Present Senior Mathematical Modeller and Statistician, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK